World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
60214
World Ranking
7501
National Ranking
3919

Paul W. Noble publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paul W. Noble sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 312 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paul W. Noble D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paul W. Noble sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paul W. Noble is affiliated with Cedars-Sinai Medical Center in the United States. Their research primarily focuses on the field of Medicine, with a strong emphasis on Pulmonary and Respiratory Medicine. Additional subfields of interest include Surgery, Molecular Biology, Infectious Diseases, and Oncology.

The scientist's main research topics include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Neonatal Respiratory Health Research
  • Medical Imaging and Pathology Studies
  • Congenital Diaphragmatic Hernia Studies
  • COVID-19 Clinical Research Studies
  • Extracellular vesicles in disease
  • Transplantation: Methods and Outcomes

Paul W. Noble has published extensively, contributing to multiple articles in notable venues. Frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • American Journal of Respiratory and Critical Care Medicine
  • American Journal of Respiratory Cell and Molecular Biology
  • European Respiratory Journal
  • UNC Libraries

Recent papers by this scientist include:

  • "Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis," 2020, American Journal of Respiratory and Critical Care Medicine
  • "Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis," 2020, International Journal of Molecular Sciences
  • "Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022," 2022, MMWR Morbidity and Mortality Weekly Report
  • "Pre-existing traits associated with Covid-19 illness severity," 2020, PLoS ONE
  • "Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs," 2020, American Journal of Respiratory and Critical Care Medicine

The scientist has collaborated frequently with several co-authors, including:

  • Dianhua Jiang
  • Barry R. Stripp
  • Jiurong Liang
  • Xue Liu
  • Changfu Yao

Best Publications

  • American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

    William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch

  • Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

    Luca Richeldi;Roland M. du Bois;Ganesh Raghu;Arata Azuma

  • A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

    Talmadge E. King;Williamson Z. Bradford;Socorro Castro-Bernardini;Elizabeth A. Fagan

  • Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.

    Paul W Noble;Carlo Albera;Williamson Z Bradford;Ulrich Costabel

  • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation

    R. J. M. Snijders;P. Noble;N. Sebire;A. Souka

  • Leptin regulates proinflammatory immune responses

    S. Loffreda;S. Q. Yang;H. Z. Lin;C. L. Karp

  • Regulation of lung injury and repair by Toll-like receptors and hyaluronan.

    Dianhua Jiang;Jiurong Liang;Juan Fan;Shuang Yu

  • Type 2 alveolar cells are stem cells in adult lung

    Christina E. Barkauskas;Michael J. Cronce;Craig R. Rackley;Emily J. Bowie

  • Signaling properties of hyaluronan receptors.

    Eva A. Turley;Paul W. Noble;Lilly Y.W. Bourguignon

  • Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

    Luca Richeldi;Ulrich Costabel;Moises Selman;Dong Soon Kim

  • Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1

    Chun Geun Lee;Robert J. Homer;Zhou Zhu;Sophie Lanone

  • Hyaluronan as an Immune Regulator in Human Diseases

    Dianhua Jiang;Jiurong Liang;Paul W. Noble

  • Hyaluronan in Tissue Injury and Repair

    Dianhua Jiang;Jiurong Liang;Paul W. Noble

  • Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition

    Jason R. Rock;Christina E. Barkauskas;Michael J. Cronce;Yan Xue

  • Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.

    Charlotte M. McKee;Margaret B. Penno;Mary Cowman;Marie D. Burdick

  • A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

    Ganesh Raghu;Kevin K. Brown;Williamson Z. Bradford;Karen Starko

  • Resolution of Lung Inflammation by CD44

    Priit Teder;R. William Vandivier;Dianhua Jiang;Jiurong Liang

  • CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex.

    Xuerong Shi;Lin Leng;Tian Wang;Wenkui Wang

  • Hyaluronan and its catabolic products in tissue injury and repair.

    Paul W Noble

  • The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis

    Fernando J. Martinez;Sharon Safrin;Derek Weycker;Karen M. Starko

Frequent Co-Authors

Ulrich Costabel
Ulrich Costabel University of Duisburg-Essen
Roland M. du Bois
Roland M. du Bois Imperial College London
Talmadge E. King
Talmadge E. King University of California, San Francisco
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Steven A. Sahn
Steven A. Sahn Medical University of South Carolina
Barry R. Stripp
Barry R. Stripp Cedars-Sinai Medical Center
Ganesh Raghu
Ganesh Raghu University of Washington
Robert J. Homer
Robert J. Homer Yale University
Kevin K. Brown
Kevin K. Brown National Jewish Health
Cory M. Hogaboam
Cory M. Hogaboam Cedars-Sinai Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn't always require the traditional path of attending medical school. There are many alternative healthcare degrees and certifications available online, catering to a variety of interests and backgrounds.

For those interested in patient care, some easy nursing programs to get into provide flexible entry requirements and faster ways to start your nursing career. Some schools even offer options for those looking for nursing schools that don't require teas or hesi, making the admissions process less stressful.

If you’re more interested in the administrative side of healthcare, earning a degree from one of the health administration degree programs can open doors to leadership roles in clinics, hospitals, or insurance companies.

Those looking for quick entry into the medical field might consider online medical billing and coding schools that accept fafsa. These programs often offer financial aid, making them accessible for students seeking affordability and job stability.

Best Scientists Citing Paul W. Noble

Trending Scientists

Recently Published Articles